Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in June - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 21
cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 24 cents per share.
    * Revenue fell 94.1% to $26.00 thousand from a year ago;
analysts
expected $230.57 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 21
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Chimerix Inc shares had fallen by 2.5% this quarter and
lost 36.6% so far this year.
    * The company reported a quarterly loss of $18.58 million.
    * Wall Street's median 12-month price target for Chimerix
Inc is
$7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.24          -0.21          Beat
 Mar. 31 2023      -0.25          -0.24          Beat
 Dec. 31 2022      -0.24          -0.24          Met
 Sep. 30 2022      2.14           2.75           Beat

Recent news on Chimerix

See all news